MY196155A - Osteoclast Inhibitors for Pain - Google Patents

Osteoclast Inhibitors for Pain

Info

Publication number
MY196155A
MY196155A MYPI2021001960A MYPI2021001960A MY196155A MY 196155 A MY196155 A MY 196155A MY PI2021001960 A MYPI2021001960 A MY PI2021001960A MY PI2021001960 A MYPI2021001960 A MY PI2021001960A MY 196155 A MY196155 A MY 196155A
Authority
MY
Malaysia
Prior art keywords
pain
osteoclast inhibitors
osteoclast
inhibitors
acid
Prior art date
Application number
MYPI2021001960A
Inventor
Herriot Tabuteau
Eric K M Dinkla
Graeme Jones
Original Assignee
Antecip Bioventures Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antecip Bioventures Ii Llc filed Critical Antecip Bioventures Ii Llc
Priority to MYPI2021001960A priority Critical patent/MY196155A/en
Publication of MY196155A publication Critical patent/MY196155A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type I.
MYPI2021001960A 2015-05-27 2015-05-27 Osteoclast Inhibitors for Pain MY196155A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2021001960A MY196155A (en) 2015-05-27 2015-05-27 Osteoclast Inhibitors for Pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2021001960A MY196155A (en) 2015-05-27 2015-05-27 Osteoclast Inhibitors for Pain

Publications (1)

Publication Number Publication Date
MY196155A true MY196155A (en) 2023-03-17

Family

ID=87798363

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021001960A MY196155A (en) 2015-05-27 2015-05-27 Osteoclast Inhibitors for Pain

Country Status (1)

Country Link
MY (1) MY196155A (en)

Similar Documents

Publication Publication Date Title
EP3180009A4 (en) Zoledronic acid dosage forms for the treatment of pain
PH12017500509A1 (en) Benzyl substituted indazoles as bub1 inhibitors
NZ702414A (en) Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12014501453B1 (en) Method of reducing exercise-induced joint pain in non-arthritic mammals
NZ724691A (en) Quinoline derivatives as smo inhibitors
TN2015000516A1 (en) Chemical compounds
MX2016003486A (en) Glucosylceramide synthase inhibitors for the treatment of diseases.
MX2017004618A (en) Heparan sulfate biosynthesis inhibitors for the treatment of diseases.
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
MY176246A (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
MX2017001352A (en) Pyrrolidinone derivatives as metap-2 inhibitors.
EA201791174A1 (en) ANTIMICOTIC CONNECTION
MX2020009444A (en) Low dose oral pharmaceutical composition of isotretinoin.
MX2016012318A (en) Amide compound.
MX2018005004A (en) Substituted indazole compounds as rorgammat inhibitors and uses thereof.
PH12017500910A1 (en) Use of sigma receptor ligands in osteoarthritis
PH12014502065A1 (en) Vesicular formulations
MX2017007245A (en) Methods of treating fibrosis.
MX2016012758A (en) Hyperosmolar composition of hyaluronic acid.
MX2018004532A (en) Combination of trazodone and gabapentin for the treatment of pain.
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
MY196155A (en) Osteoclast Inhibitors for Pain
MX369174B (en) Process for preparing a compound.
EA201690214A1 (en) METHOD FOR TREATING HYPERTROPHIC CARDIOMYOPATHY